Register for Webinar

Webinar

Liquid biopsy for post-treatment cancer monitoring in dogs

After a dog is diagnosed with cancer and receives therapy, the current standard of care relies heavily on physical exam and imaging to assess disease status and monitor for cancer recurrence. However, these tools may not be sensitive enough to detect the presence of residual disease following excisional surgery, or to detect early evidence of cancer recurrence following therapeutic intervention. Blood-based liquid biopsy, a clinically validated test for cancer detection, may provide value as a new, noninvasive tool to support post-diagnosis monitoring of cancer in dogs. This session will review the performance of a next-generation sequencing-based liquid biopsy test for detection of residual disease and cancer recurrence following treatment. Case studies demonstrating the use of liquid biopsy in a post-diagnosis setting will be presented.

Race: 20-977078

This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval.

Additionally, PetDx is approved as a New York State sponsor of continuing education for veterinarians and veterinary technicians.

Speaker

Andi Flory

DVM, DACVIM (Oncology)
PetDx Chief Medical Officer 

Register for Webinar